| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.52B | +0.3% |
| Cost of Revenue | $1.36B | -0.5% |
| R&D Expense | $8.7M | -1.1% |
| SG&A Expense | $104.8M | +11.4% |
| Pre-tax Income | $54.4M | +19.4% |
| Income Tax | $5.1M | +260.8% |
| Net Income | $49.3M | +11.6% |
| EPS (Basic) | $1.83 | +10.9% |
| EPS (Diluted) | $1.80 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $19.8M | +1.0% |
| Inventory | $236.5M | +11.4% |
| Current Assets | $440.6M | +13.8% |
| Total Assets | $1.71B | +7.0% |
| Current Liabilities | $390.0M | +9.2% |
| Total Liabilities | $890.9M | +8.6% |
| Stockholders' Equity | $815.2M | +5.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $122.9M | -9.3% |
| Capital Expenditures | $116.4M | -12.9% |
| Investing Cash Flow | -$122.6M | +14.2% |
| Financing Cash Flow | -$47K | +98.3% |
| Free Cash Flow | $6.4M | +279.5% |
| +11.1% |